Skip to content

Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, sold KYMR on Jul 1, 2026

Data as of Oct 16

▼ SELL$389K3,336 shares at $116.56Nello Mainolfi Chief Executive OfficerKYMR Kymera Therapeutics, Inc.
Watch KYMR
Traded
Jul 1, 2026
Disclosed
Jul 2, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, sold KYMR on Jul 1, 2026TRADEDDISCLOSED
KYMRSimilar stocks (XLV — its sector index fund), rebased to KYMR's price on the disclosure day
KYMR since disclosure
−7.7%
after the sale
Similar stocks (XLV) since disclosure
+7.9%
XLV — its sector index fund

Change in closing price from Jul 2, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLNello Mainolfi Chief Executive OfficerKYMR Kymera Therapeutics, Inc.$755Kdisclosed Jul 2 · filed 1 day after the trade
  2. ▼ SELLNello Mainolfi Chief Executive OfficerKYMR Kymera Therapeutics, Inc.$5.1Mdisclosed Jul 2 · filed 1 day after the trade
  3. ▼ SELLNello Mainolfi Chief Executive OfficerKYMR Kymera Therapeutics, Inc.$212Kdisclosed Jul 2 · filed 1 day after the trade
  4. ▼ SELLNello Mainolfi Chief Executive OfficerKYMR Kymera Therapeutics, Inc.$2.8Mdisclosed Jul 2 · filed 1 day after the trade

See every trade on KYMR →